Erlotinib Completed Phase 1 Trials for Neoplasms, Head and Neck / Cancer of Head and Neck Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT01116336Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck